Eric Lippert

16PUBLICATIONS
69CO-AUTHORS
Medical infection agents (incl. prions)NeurogeneticsHaematological tumoursPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 04, 2026
Non-invasive multiparametric characterization of essential thrombocythemia, premyelofibrosis, and overt myelofibrosis.

|Jan 23, 2026
De novo variants in the splicing factor gene SF3B1 are associated with neurodevelopmental disorders.

Kevin Uguen, Tiffany Bergot, Marie-Pier Scott-Boyer

|Dec 23, 2025
Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.

Alexandre Guy, Olivier Mansier, Matisse Decilap

|Jun 18, 2025
A molecular signature predicts hematologic evolution in polycythemia vera patients.

Olivier Mansier, Eric Lippert, Lina Benajiba

|Feb 26, 2024
CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.

Laura Aubin, Rúben Vilas Boas, Rafael Daltro De Oliveira

|Dec 26, 2023
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification.

Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur

Pageof 3

Frequent Collaborators

8 joint publications

Damien Luque Paz

7 joint publications

Jean-Christophe Ianotto

4 joint publications

Jérémie Riou

4 joint publications

Léa Sureau